Innovations in Retinal Scanning, Neural Imaging, Post-operative Imaging, MRI Diagnostics, Breast Cancer Imaging, and Drug Efficacy Assessing Tools - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 24, 2018--The “Innovations in Retinal Scanning, Neural Imaging, Post-operative Imaging, MRI Diagnostics, Breast Cancer Imaging, and Drug Efficacy Assessing Tools” report has been added to ResearchAndMarkets.com’s offering.
The latest issue of Medical Imaging and Diagnostics TOE profiles innovations profiles in the medical imaging and diagnostics industry. Some of the profiles covered include development of an MRI without using contrasting agents, combined digital breast screening for cancer diagnosis, artificial intelligence-based breast imaging, automated retinal scanning solution, neural imaging, and surgical site markers for improved post-operative imaging.
Medical Imaging and Diagnostics TechVision Opportunity Engine (TOE)’s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered.
Key Topics CoveredMRI Diagnostics without Using Contrasting Agents Diamonds for Lowering the Cost of Medical Imaging Combined Digital Breast Screening To Detect Various Cancers Simulation Tool to Estimate the Efficacy of HIV Drugs Industry Collaboration to develop AI-based Breast Imaging Application Automated Retinal Scanning for Diagnosing Ophthalmic Disorders Near-infrared Imaging Approach for Neural Imaging Diagnosing Neurodegenerative Disorders by Tracking Eye Movements Artificial Intelligence Platform for the Diagnosis of Infectious Diseases Surgical Site Markers for Improved Post-operative Imaging Database of Key Industry Participants
For more information about this report visit https://www.researchandmarkets.com/research/77bnjj/innovations_in?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180724005863/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Women’s Health,Breast Cancer Drugs,Mammography,Magnetic Resonance Imaging (MRI),Biometrics
INDUSTRY KEYWORD: HEALTH RADIOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/24/2018 02:15 PM/DISC: 07/24/2018 02:16 PM